Stefan Preković

University Medical Center Utrecht — Netherlands

Medicine · Health Sciences

23h-index2.2kcitations131works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(37), Estrogen and related hormone effects(22), Cancer Research and Treatments(20), Genomics and Chromatin Dynamics(13), Epigenetics and DNA Methylation(13)

Publications131 total

Beyond the chaos: How architecture structures tumour biology
FEBS Journal·2026Open Access
Classical enhancers couple <i>cis</i> -regulatory logic with transcriptional condensates and 3D genome architecture
2026Open Access
Microplastics as environmental modifiers of lung disease
EMBO Molecular Medicine·2025· 1 citedOpen Access
Automated <scp>FRAP</scp> microscopy for high‐throughput analysis of protein dynamics in chromatin organization and transcription
FEBS Open Bio·2025Open Access
Kaiso (ZBTB33) engages with non-canonical binding motifs to regulate DNA damage responses in breast cancer cells
2025Open Access
Worse prognosis for breast cancer diagnosed in advanced pregnancy and shortly postpartum: an update of the Dutch pregnancy-associated breast cancer cohort
Breast Cancer Research and Treatment·2025· 5 citedOpen Access
Supplementary Figure 3 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 2 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 14 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 8 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 9 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Table 2 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 1 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Data from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 13 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 10 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 6 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 7 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 12 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
Supplementary Figure 4 from Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness
2025Open Access
page 1 of 7Next →

Frequent Co-authors

Wilbert Zwart(25), Frank Claessens(17), Christine Helsen(14), Thomas Van den Broeck(11), Steven Joniau(10), Isabel Mayayo‐Peralta(9), Roderick L. Beijersbergen(9), Maarten Altelaar(9), Karianne Schuurman(8), Cor Lieftink(8), Liesbeth Hoekman(8), Jos Jonkers(6), Elien Smeets(6), Adriaan B. Houtsmuller(5), Lien Spans(5), Florian Handle(5), Hans Teunissen(5), Elzo de Wit(5), Catrin Lutz(5), Lodewyk F.A. Wessels(4)